Published - Tue, 09 Aug 2022
1. The acute, potentially fatal illness known as anaphylaxis is brought on by the release of chemical mediators from mast cells and basophils. The primary preformed chemical mediator is histamine. Proteoglycans, enzymes in the Hageman factor pathway, neutrophil chemotactic factor, and eosinophil chemotactic factor are more examples.
2. Anaphylactic versus anaphylactoid reactions
a) Unlike anaphylactoid reactions, which happen through a variety of pathways and directly degrade mast cells, anaphylactic reactions entail antibody-antigen interactions mediated by immunoglobulin E (IgE).
i) Anaphylaxis
ii) Anaphylactoid reactions
b) Anaphylactic and anaphylactoid reactions are clinically the same because comparable mediators produce similar target organ sequelae. Treatment for both reactions is directed at the end-organ signs and is the same. Because of these similarities, the term anaphylaxis will be used to encompass both IgE and non-IgE reactions.
CLINICAL FEATURES
1. Symptoms are most likely to occur minutes after exposure to the triggering agent but may occur in seconds to a few hours. Early or subtle signs and symptoms of anaphylaxis include cutaneous flushing, pruritus, voice change, and a sense of impending doom. Usually, the later the symptoms occur, the less severe the reaction.
2. Clinical findings prominently involve the skin (urticaria), the upper airways (laryngeal edema, hoarseness, stridor), the lower airways (bronchospasm), and the cardiovascular system (hypotension, vasodilation, dysrhythmia, myocardial infarction [MI]), and the gastrointestinal system (abdominal cramps).
3. Death may occur from respiratory causes (70%) or cardiovascular causes (25%). (Autopsy findings include acute pulmonary hyperinflation, laryngeal edema, visceral congestion, pulmonary edema, intra-alveolar hemorrhage, urticaria/angioedema, and MI.)
Clinical Manifestations of Anaphylaxis
Organ System | Reaction |
Cutaneous | - Diaphoresis - Flushing - Pruritus - Piloerection - Urticaria - Angioedema |
Head, ears, eyes, nose, and throat | -Conjunctivitis -Metallic taste -Hoarseness -Rhinorrhea/nasal congestion -Stridor |
Pulmonary | - Dyspnea - Cough - Tachypnea - Wheezing |
Cardiovascular | - Tachycardia - Dysrhythmia - Hypotension |
Gastrointestinal | -Abdominal cramps -Diarrhea Nausea and vomiting |
Neurologic | - Altered mental status - Dizziness - Seizure |
DIFFERENTIAL DIAGNOSES: The diagnosis of anaphylaxis is generally readily apparent based on history and clinical findings but may sometimes be confused with overlapping or other distinct entities.
Differential diagnosis involves the following:
1. Judging whether the symptoms and signs represent a simple allergic or pseudoallergic reaction (e.g., asthma exacerbation, urticaria), as opposed to anaphylaxis
2. Considering whether some of the symptoms and signs represent a secondary process (e.g., MI).
3. Determining if a completely different type of problem could be occurring (e.g., drug intoxication, hypovolemic shock).
Rigomo is a leading online education platform that offers a wide range of courses to help individuals enhance their skills and achieve their career goals. With our user-friendly interface and expert instructors, we strive to provide high-quality education to everyone, anytime and anywhere. Join us today and take the first step towards a brighter future.
Rigomo is an e-learning platform that was founded in 2019 by a team of dedicated professionals with a passion for revolutionizing the way people learn. The platform offers a range of online courses that cover various industries, including business, technology, healthcare, and more.
Rigomo's courses are designed to be interactive and engaging, with a focus on practical skills that learners can apply in their careers. The platform uses a combination of video lectures, quizzes, and hands-on projects to help learners master the subject matter.
Rigomo is committed to providing affordable and accessible education to people around the world. The platform offers a range of pricing options, including monthly and annual subscriptions, as well as pay-as-you-go options for individual courses.
Since its launch, Rigomo has received numerous accolades for its innovative approach to e-learning. The platform has helped thousands of learners across the globe acquire new skills and advance their careers.
As Rigomo continues to grow, the team remains committed to providing high-quality education that is accessible to all. The platform is constantly updating its courses and features to ensure that learners have access to the latest tools and technologies.
Sun, 12 May 2024
Thu, 25 Apr 2024
Wed, 24 Apr 2024
Write a public review